Hypertension Research
Online ISSN : 1348-4214
Print ISSN : 0916-9636
ISSN-L : 0916-9636
Experimental studies
Eicosapentaenoic Acid Suppresses Basal and Insulin-Stimulated Endothelin-1 Production in Human Endothelial Cells
Keigo CHISAKIYukichi OKUDASeiji SUZUKITakashi MIYAUCHIMasaaki SOMANorio OHKOSHIHirohito SONENobuhiro YAMADAToshiaki NAKAJIMA
Author information
JOURNAL FREE ACCESS

2003 Volume 26 Issue 8 Pages 655-661

Details
Abstract
cis-Polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) are the major fatty acids contained in fish oil, and are known to affect the various physiological properties of cell membranes in humans. The present study investigated the effects of polyunsaturated fatty acids on endothelin-1 (ET-1) production in human umbilical vein endothelial cells (HUVECs) and on insulin activity. After addition of various concentrations of EPA, docosahexaenoic acid, arachidonic acid, or linoleic acid to a culture medium, the concentration of ET-1 was measured using ELISA, and that of ET-1 mRNA was determined by RT-PCR. The results showed that EPA had the strongest inhibitory effect (p <0.05) on both basal ET-1 production and ET-1 mRNA levels. In addition, insulin (1μmol/l) markedly increased ET-1 production, and EPA also significantly decreased the effect induced by insulin. Pretreatment with Ca2+ chelator EGTA (1 mmol/l), NOS inhibitor L-NAME (300μmol/l), or calmodulin antagonist W-7 (300μmol/l) inhibited NO production by EPA (100μmol/l), but these pretreatments had no effect on ET-1 production by EPA. These findings suggest that EPA reduces basal and insulin-enhanced ET-1 production by inhibiting ET-1 mRNA production. These effects of EPA may contribute to its vasorelaxant and anti-atherosclerotic effects. (Hypertens Res 2003; 26: 655-661)
Content from these authors
© 2003 by the Japanese Society of Hypertension
Previous article Next article
feedback
Top